Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries

Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries

Abstract Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in young children. A number of mathematical models have been used to assess the cost-effectiveness of RSV prevention strategies, but these have not been designed for ease of use by multidisciplinary teams...

Full description

Bibliographic Details
Main Authors: Sarwat Mahmud, Ranju Baral, Colin Sanderson, Clint Pecenka, Mark Jit, You Li, Andrew Clark
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Medicine
Subjects:
RSV
LMICs
Maternal vaccine
Monoclonal antibody
Economic evaluation
Online Access:https://doi.org/10.1186/s12916-023-02827-5

Internet

https://doi.org/10.1186/s12916-023-02827-5

Similar Items